-
model-based control tailored to systems like NudgeFlow. The framework decomposes the global control problem into smaller local problems for each zone or room, enabling independent optimization with local
-
. These will be targeted with gene therapeutic agents (GTAs) delivered during EVLP to selectively modulate immune responses and improve long-term outcomes. The DC1 objectives are: To develop a mouse model
Searches related to agent based modelling
Enter an email to receive alerts for agent-based-modelling positions